Rekover Therapeutics

Rekover Therapeutics is looking to repair nerve damage caused by neurodegenerative diseases through novel application drug therapy. Whereas traditional treatment avenues for diseases such as multiple sclerosis have been symptom treatment and slowing the rate of disability accumulation through medications and physical therapies, Rekover seeks to restore the damaged nerves, thereby reversing the disease’s progression.

A joint venture out of Victoria University of Wellington and the University of Kentucky, Rekover is based in Wellington. The company has a strong scientific team with wide access to a variety of critical resources across multiple disciplines.